MedAssets Stock Price, News & Analysis (NASDAQ:MDAS)

$31.35 0.01 (0.03 %)
(As of 12/13/2017 05:54 AM ET)
Previous Close$31.34
Today's Range$31.30 - $31.35
52-Week Range$17.00 - $31.35
Volume3.15 million shs
Average Volume1.79 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About MedAssets (NASDAQ:MDAS)

MedAssets logoMedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company’s technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company’s solutions across decentralized health care organizations, providing standardization and compliance.

Receive MDAS News and Ratings via Email

Sign-up to receive the latest news and ratings for MDAS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry IT Services & Consulting
Sub-IndustryHealth Care Technology
SectorTechnology
SymbolNASDAQ:MDAS
CUSIP58404510
Phone+1-678-3232500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.59)
Net IncomeN/A
Net Margins-1.18%
Return on Equity-2.00%
Return on Assets-0.54%

Miscellaneous

EmployeesN/A
Outstanding Shares60,000,000

MedAssets (NASDAQ:MDAS) Frequently Asked Questions

What is MedAssets' stock symbol?

MedAssets trades on the NASDAQ under the ticker symbol "MDAS."

How were MedAssets' earnings last quarter?

MedAssets, Inc. (NASDAQ:MDAS) announced its quarterly earnings data on Wednesday, July, 29th. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.27 by $0.04. The technology company earned $190.40 million during the quarter, compared to the consensus estimate of $187.45 million. MedAssets had a negative net margin of 1.18% and a negative return on equity of 2.00%. The firm's quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.30 earnings per share. View MedAssets' Earnings History.

Who are some of MedAssets' key competitors?

How do I buy MedAssets stock?

Shares of MedAssets can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MedAssets' stock price today?

One share of MedAssets stock can currently be purchased for approximately $31.35.

How can I contact MedAssets?

MedAssets' mailing address is 100 N Point Ctr E Ste 200, ALPHARETTA, GA 30022-8261, United States. The technology company can be reached via phone at +1-678-3232500.


MarketBeat Community Rating for MedAssets (MDAS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  199 (Vote Outperform)
Underperform Votes:  288 (Vote Underperform)
Total Votes:  487
MarketBeat's community ratings are surveys of what our community members think about MedAssets and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MedAssets (NASDAQ:MDAS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AHold
Consensus Rating Score: N/AN/AN/A2.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

MedAssets (NASDAQ:MDAS) Consensus Price Target History

Price Target History for MedAssets (NASDAQ:MDAS)

MedAssets (NASDAQ:MDAS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/27/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
1/25/2016Canaccord GenuityReiterated RatingHoldN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

MedAssets (NASDAQ:MDAS) Earnings History and Estimates Chart

Earnings by Quarter for MedAssets (NASDAQ:MDAS)

MedAssets (NASDAQ MDAS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2015Q315$0.28$0.27$187.34 million$117.20 millionViewN/AView Earnings Details
7/29/2015Q2$0.27$0.31$187.45 million$190.40 millionViewListenView Earnings Details
4/29/2015Q115$0.30$0.31$184.33 million$185.58 millionViewN/AView Earnings Details
2/17/2015Q414$0.39$0.39$195.00 million$198.20 millionViewN/AView Earnings Details
10/29/2014Q314$0.31$0.34$172.50 million$175.70 millionViewListenView Earnings Details
7/30/2014Q214$0.29$0.30$175.70 million$175.42 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.27$172.30 million$170.87 millionViewListenView Earnings Details
2/26/2014Q413$0.28$0.30$165.64 million$170.50 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.26$0.30$167.64 million$170.70 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.30$0.41$164.75 million$172.84 millionViewN/AView Earnings Details
2/20/2013Q4 2012$0.28$0.27$159.84 million$163.80 millionViewN/AView Earnings Details
10/30/2012$0.26$0.32ViewN/AView Earnings Details
8/1/2012$0.22$0.28ViewN/AView Earnings Details
5/2/2012$0.18$0.24ViewN/AView Earnings Details
2/23/2012$0.32$0.32ViewN/AView Earnings Details
11/3/2011$0.16$0.26ViewN/AView Earnings Details
8/1/2011$0.16$0.23ViewN/AView Earnings Details
5/5/2011$0.16$0.17ViewN/AView Earnings Details
2/24/2011$0.22$0.18ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

MedAssets (NASDAQ:MDAS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for MedAssets (NASDAQ:MDAS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

MedAssets (NASDAQ MDAS) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for MedAssets (NASDAQ:MDAS)
Institutional Ownership by Quarter for MedAssets (NASDAQ:MDAS)

MedAssets (NASDAQ MDAS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/26/2015John A BardisDirectorSell2,000$19.73$39,460.00View SEC Filing  
2/24/2015John A BardisDirectorSell100,000$19.45$1,945,000.00View SEC Filing  
2/19/2015R Halsey WiseCEOBuy110,300$18.15$2,001,945.00View SEC Filing  
11/26/2014Keith L ThurgoodInsiderSell5,681$19.54$111,006.74View SEC Filing  
11/12/2014Harris Iv HymanDirectorSell3,334$20.50$68,347.00View SEC Filing  
11/11/2014John A BardisCEOSell100,000$20.02$2,002,000.00View SEC Filing  
11/7/2014John A BardisCEOSell191,833$20.74$3,978,616.42View SEC Filing  
11/4/2014John A BardisCEOSell208,167$21.48$4,471,427.16View SEC Filing  
10/28/2014Jonathan H GlennInsiderSell7,300$22.62$165,126.00View SEC Filing  
10/27/2014Jonathan H GlennInsiderSell500$22.50$11,250.00View SEC Filing  
8/13/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/10/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/1/2014Charles O GarnerCFOSell3,167$22.81$72,239.27View SEC Filing  
6/12/2014Terrence J MulliganDirectorSell1,000$23.30$23,300.00View SEC Filing  
5/14/2014Terrence MulliganDirectorSell1,000$22.93$22,930.00View SEC Filing  
5/2/2014R Halsey WiseDirectorBuy8,950$22.31$199,674.50View SEC Filing  
4/10/2014Terrence MulliganDirectorSell1,000$24.56$24,560.00View SEC Filing  
3/13/2014Terrence MulliganDirectorSell1,000$25.24$25,240.00View SEC Filing  
2/28/2014Charles GarnerCFOSell8,949$24.05$215,223.45View SEC Filing  
2/24/2014Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
1/16/2014Charles GarnerCFOSell15,207$20.83$316,761.81View SEC Filing  
1/16/2014Terrence MulliganDirectorSell2,000$21.97$43,940.00View SEC Filing  
11/26/2013John RutherfordDirectorSell13,000$21.41$278,330.00View SEC Filing  
11/21/2013Bruce WessonDirectorSell60,263$20.54$1,237,802.02View SEC Filing  
11/15/2013Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
11/8/2013John BardisCEOSell200,000$22.04$4,408,000.00View SEC Filing  
10/22/2013Lance M CulbrethCAOSell2,000$26.45$52,900.00View SEC Filing  
10/8/2013Terrence MulliganDirectorSell1,000$24.64$24,640.00View SEC Filing  
9/17/2013Terrence MulliganDirectorSell1,000$24.21$24,210.00View SEC Filing  
9/11/2013Lance M CulbrethCAOSell4,000$24.23$96,920.00View SEC Filing  
9/10/2013Jonathan H GlennInsiderSell12,268$24.00$294,432.00View SEC Filing  
8/29/2013Charles GarnerCFOSell2,017$23.02$46,431.34View SEC Filing  
8/29/2013Harris Iv HymanDirectorSell3,199$23.26$74,408.74View SEC Filing  
8/26/2013Harris Iv HymanDirectorSell5,985$23.50$140,647.50View SEC Filing  
8/23/2013C PiccoloDirectorSell17,487$22.94$401,151.78View SEC Filing  
8/23/2013John BardisCEOSell17,304$23.04$398,684.16View SEC Filing  
8/15/2013John BardisCEOSell10,000$22.87$228,700.00View SEC Filing  
8/14/2013Terrence MulliganDirectorSell5,000$23.50$117,500.00View SEC Filing  
8/9/2013John RutherfordDirectorSell50,000$23.62$1,181,000.00View SEC Filing  
8/5/2013Lance M CulbrethCAOSell22,866$23.34$533,692.44View SEC Filing  
8/2/2013Gregory StrobelInsiderSell4,025$22.78$91,689.50View SEC Filing  
8/2/2013Terrence MulliganDirectorSell29,446$23.39$688,741.94View SEC Filing  
7/23/2013Michael Patrick NolteCOOSell20,000$21.04$420,800.00View SEC Filing  
7/17/2013Lance M CulbrethCAOSell4,500$20.45$92,025.00View SEC Filing  
7/16/2013Michael Patrick NolteCOOSell19,222$19.63$377,327.86View SEC Filing  
7/16/2013Rand A BallardInsiderSell13,163$20.00$263,260.00View SEC Filing  
7/16/2013Terrence J MulliganDirectorSell55,000$20.00$1,100,000.00View SEC Filing  
5/10/2013Lance M CulbrethCAOSell16,000$18.54$296,640.00View SEC Filing  
3/25/2013Charles O GarnerCFOSell15,038$19.38$291,436.44View SEC Filing  
11/27/2012Gregory A StrobelInsiderSell10,000$16.24$162,400.00View SEC Filing  
11/27/2012John A BardisCEOSell107,550$16.51$1,775,650.50View SEC Filing  
11/14/2012John A BardisCEOSell71,340$16.34$1,165,695.60View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

MedAssets (NASDAQ MDAS) News Headlines

Source:

SEC Filings

MedAssets (NASDAQ:MDAS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

MedAssets (NASDAQ:MDAS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

MedAssets (NASDAQ MDAS) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.